CECLOR CD

LOE Approaching

cefaclor

Eli Lilly and Company
NDAORALTABLET, EXTENDED RELEASE
Approved
Jun 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

CLINICAL PHARMACOLOGY Cefaclor is well absorbed after oral administration to fasting subjects. Total absorption is the same whether the drug is given with or without food; however, when it is taken with food, the peak concentration achieved is 50% to 75% of that observed when the drug is…

Indications (5)

the treatment of the following infectionsHaemophilus influenzaestaphylococciStreptococcus pyogenes Note: β-lactamase-negativeampicillin-resistant (BLNAR) strains of Haemophilus influenzae should be considered resistant to cefaclor despite apparent in vitro susceptibility of some BLNAR strains

Clinical Trials (1)

NCT00257140Phase 2/3Completed

A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria

Started Jun 1931
367 enrolled
BronchitisBronchitis, Chronic
Company
Eli Lilly and Company
Eli Lilly and Company
INDIANAPOLIS, IN
838 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers